4//SEC Filing
Riebman Jerome 4
Accession 0001415889-22-009536
CIK 0001708527other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:01 PM ET
Size
9.0 KB
Accession
0001415889-22-009536
Insider Transaction Report
Form 4
Riebman Jerome
Chief Medical Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-09-08+14,758→ 20,093 total - Tax Payment
Class A Common Stock
2022-09-08$7.30/sh−5,104$37,259→ 14,989 total - Exercise/Conversion
Restricted Stock Units
2022-09-08−14,758→ 0 total→ Class A Common Stock (14,758 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
- [F2]Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.
- [F3]Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
- [F4]The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
Related Parties
1- filerCIK 0001825821
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:01 PM ET
- Size
- 9.0 KB